While 81% of human resource decision-makers feel their employees would be interested in GLP-1 weight loss medications, only 25% cover GLP-1s currently – but that figure is expected to double next year, according to a new survey from Accolade.
GLP-1 medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as an effective drug for weight loss and obesity.
